Lemborexant Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5mg, 10 mg
Reference Brands: Dayvigo (USA)
Category:
Sleep Disorders
Lemborexant is a dual orexin receptor antagonist used for treating adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. It works by competitively blocking the wake-promoting orexin receptors (OX1 and OX2), thus reducing the “wake drive” and enabling sleep. Clinical trials have shown improvements in both sleep onset latency and wake-after-sleep-onset, with maintenance of effect over up to 12 months and a favorable tolerability profile.
Lemborexant is available in Tablets
and strengths such as 5mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lemborexant is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lemborexant can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lemborexant is a medication used for the management and treatment of insomnia, a common sleep disorder characterized by difficulty falling asleep or staying asleep. It belongs to the class of medicines known as dual orexin receptor antagonists, which work by blocking the activity of orexin neuropeptides in the brain that promote wakefulness. By reducing these wake signals, lemborexant helps regulate the sleep–wake cycle and supports the initiation and maintenance of sleep.
This medication is considered a valuable option in the treatment of insomnia, particularly in patients who require improved sleep quality and duration. Lemborexant is prescribed under medical supervision, and its use involves careful consideration of dosing, patient condition, and possible interactions with other medications. Healthcare professionals also monitor patients for effectiveness and potential adverse effects during treatment. With its targeted mechanism of action, lemborexant contributes to better sleep management and improved overall functioning in individuals experiencing insomnia and related sleep disturbances.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing